INT139527

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.43
First Reported 2006
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 16
Total Number 17
Disease Relevance 4.66
Pain Relevance 0.98

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (PAEP) nucleolus (PAEP) nucleus (PAEP)
Anatomy Link Frequency
tube 8
Plasma 2
arm 2
upper 2
PAEP (Homo sapiens)
Pain Link Frequency Relevance Heat
imagery 62 96.40 Very High Very High Very High
abdominal pain 3 90.24 High High
Pain 18 88.88 High High
Inflammation 11 83.36 Quite High
Versed 3 53.60 Quite High
psoriasis 21 50.00 Quite Low
rheumatoid arthritis 1 30.88 Quite Low
depression 6 20.00 Low Low
amygdala 66 5.00 Very Low Very Low Very Low
insula 62 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Infection 50 99.20 Very High Very High Very High
Malignant Neoplastic Disease 5 98.92 Very High Very High Very High
Wound Infection 12 98.28 Very High Very High Very High
Hepatitis 24 96.60 Very High Very High Very High
Hepatitis B Virus Infection 120 95.80 Very High Very High Very High
Death 39 92.68 High High
Injury 7 90.44 High High
Abdominal Pain 3 90.24 High High
Pain 9 88.88 High High
Hepatitis C Virus Infection 13 86.44 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
This single centre, two arm, randomised, controlled, double blind clinical trial indicates that infection prophylaxis with 20 ml co-trimoxazole, deposited in the PEG catheter immediately after its insertion, prevents wound infection at least as effectively as pre-operative intravenous cefuroxime in patients undergoing PEG.
Positive_regulation (deposited) of Gene_expression (catheter) of PEG in arm associated with wound infection and infection
1) Confidence 0.43 Published 2010 Journal BMJ : British Medical Journal Section Body Doc Link PMC2896486 Disease Relevance 0.36 Pain Relevance 0
Paralleling GD1, the design matrix for GD2 had 8 conditions: (1) ratings; (2) flow in and volume <250 ml; (3) flow in and 250 ml< volume <500 ml; (4) flow in and 500 ml< volume <700 ml; (5) null flow and volume?
Positive_regulation (for) of Gene_expression (had) of GD2
2) Confidence 0.37 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2729391 Disease Relevance 0 Pain Relevance 0.14
Paralleling GD1, the design matrix for GD2 had 8 conditions: (1) ratings; (2) flow in and volume <250 ml; (3) flow in and 250 ml< volume <500 ml; (4) flow in and 500 ml< volume <700 ml; (5) null flow and volume?
Positive_regulation (for) of Gene_expression (had) of GD1
3) Confidence 0.37 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2729391 Disease Relevance 0 Pain Relevance 0.14
Factors that promote routine use of PEG tube feeding
Positive_regulation (use) of Gene_expression (feeding) of PEG in tube
4) Confidence 0.36 Published 2007 Journal BMC Geriatr Section Body Doc Link PMC1997114 Disease Relevance 0 Pain Relevance 0
Choosing PEG tubes as the method to deliver ANH was partly attributed to reimbursement issues.
Positive_regulation (deliver) of Gene_expression (deliver) of PEG in tubes
5) Confidence 0.36 Published 2007 Journal BMC Geriatr Section Body Doc Link PMC1997114 Disease Relevance 0 Pain Relevance 0
Finally, the current reimbursement system provides incentives favoring PEG tube instead of other ANH methods.
Positive_regulation (favoring) of Gene_expression (tube) of PEG in tube
6) Confidence 0.36 Published 2007 Journal BMC Geriatr Section Body Doc Link PMC1997114 Disease Relevance 0.23 Pain Relevance 0
The urgency of PEP demands a rapid induction of neutralising antibody using minimal amounts of vaccine in all recipients including the ?
Positive_regulation (demands) of Gene_expression (urgency) of PEP
7) Confidence 0.35 Published 2008 Journal PLoS Neglected Tropical Diseases Section Body Doc Link PMC2292256 Disease Relevance 0.77 Pain Relevance 0
The blank PLA–PEG nanoparticles did not enhance the signal intensity, which confirmed the Gd–DTPA was absorbed to the surface of the nanoparticles.Fig. 5Imaging intensity of nanocomplexes dependent on the dose of Gd–DTPA

Stability of the Nanocomplexes in Human Plasma

Neg (not) Positive_regulation (enhance) of Gene_expression (nanoparticles) of PEG in Plasma
8) Confidence 0.35 Published 2009 Journal Nanoscale Res Lett Section Body Doc Link PMC2894099 Disease Relevance 0 Pain Relevance 0.27
Glycodelin expression was found to be significantly higher in days 19 - 23 compared to the level in days 12-14 (0.819 ± 0.564 versus 0.072 ± 0.343, P < 0.05).
Positive_regulation (higher) of Gene_expression (expression) of Glycodelin
9) Confidence 0.33 Published 2009 Journal Reprod Biol Endocrinol Section Body Doc Link PMC2805671 Disease Relevance 0 Pain Relevance 0
The average weight molecular weights used for PEG are 4000, 6000 and 10,000, respectively, and the procedure of chemical modification for PEGs was conducted by a two-step protocol: (1) synthesis of N-chloroacetyl-metaxalone; (2) synthesis of PEG(4000)-Met, PEG(6000)-Met and PEG(10000)-Met.
Positive_regulation (conducted) of Gene_expression (synthesis) of PEG
10) Confidence 0.22 Published 2007 Journal Int J Pharm Section Abstract Doc Link 17067768 Disease Relevance 0.18 Pain Relevance 0.09
The average weight molecular weights used for PEG are 4000, 6000 and 10,000, respectively, and the procedure of chemical modification for PEGs was conducted by a two-step protocol: (1) synthesis of N-chloroacetyl-metaxalone; (2) synthesis of PEG(4000)-Met, PEG(6000)-Met and PEG(10000)-Met.
Positive_regulation (conducted) of Gene_expression (synthesis) of PEG
11) Confidence 0.22 Published 2007 Journal Int J Pharm Section Abstract Doc Link 17067768 Disease Relevance 0.18 Pain Relevance 0.09
The average weight molecular weights used for PEG are 4000, 6000 and 10,000, respectively, and the procedure of chemical modification for PEGs was conducted by a two-step protocol: (1) synthesis of N-chloroacetyl-metaxalone; (2) synthesis of PEG(4000)-Met, PEG(6000)-Met and PEG(10000)-Met.
Positive_regulation (conducted) of Gene_expression (synthesis) of PEG
12) Confidence 0.22 Published 2007 Journal Int J Pharm Section Abstract Doc Link 17067768 Disease Relevance 0.18 Pain Relevance 0.09
Fried et al. [28•] showed that monitoring serum HBeAg levels during PEG-IFN ?
Positive_regulation (during) of Gene_expression (monitoring) of PEG
13) Confidence 0.22 Published 2010 Journal Curr Hepat Rep Section Body Doc Link PMC2945466 Disease Relevance 0.72 Pain Relevance 0
Different patterns of viral decline during PEG-IFN ?
Positive_regulation (during) of Gene_expression (-) of PEG
14) Confidence 0.22 Published 2010 Journal Curr Hepat Rep Section Body Doc Link PMC2945466 Disease Relevance 0.73 Pain Relevance 0
RIG versus PEG in upper gastrointestinal malignancy
Positive_regulation (versus) of Gene_expression (versus) of PEG in upper associated with malignant neoplastic disease
15) Confidence 0.16 Published 2008 Journal Int Arch Med Section Body Doc Link PMC2526080 Disease Relevance 0.52 Pain Relevance 0.16
The advantages of the PEG tube such as; ease in feeding, cosmetic acceptability, increase in the survival period and its impact on the physical well being of the patients were also enquired.
Positive_regulation (increase) of Gene_expression (tube) of PEG in tube
16) Confidence 0.15 Published 2006 Journal BMC Gastroenterol Section Body Doc Link PMC1676010 Disease Relevance 0.13 Pain Relevance 0
The patient was re-treated with PEG IFN ?
Positive_regulation (with) of Gene_expression (treated) of PEG
17) Confidence 0.03 Published 2007 Journal J Med Case Reports Section Body Doc Link PMC2075503 Disease Relevance 0.65 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox